We have collected information about Novel Drug Delivery Technologies For The Treatment Of Rheumatoid Arthritis for you. Follow the links to find out details on Novel Drug Delivery Technologies For The Treatment Of Rheumatoid Arthritis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491719/
Saltzman, et al. disclosed the use of cathepsin Z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases. The increased expression and/or activity of cathepsin Z in dendritic cells, is associated with increased dendritic cell antigen presentation.Author: Ling Dong Quan, Geoffrey Milton Thiele, Jun Tian, Dong Wang
http://biomedpharmajournal.org/vol12no1/novel-drug-delivery-systems-for-rheumatoid-arthritis-an-approach-to-better-patient-compliance/
Novel Drug Delivery Systems for Rheumatoid Arthritis: An Approach to Better Patient Compliance Sangeeta Mohanty*, Sthitapragnya Panda, Aslesha Bhanja, Abhisek Pal and Si Sudam Chandra School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan Deemed to …Author: Sangeeta Mohanty, Sthitapragnya Panda, Aslesha Bhanja, Abhisek Pal, Si Sudam Chandra
http://ispub.com/IJMT/5/1/5025
Apart from oral, parenteral and topical drug delivery systems, several innovative drug delivery approaches in treatment of rheumatoid arthritis have been developed. Hypoxia is a common finding in RA which facilitates delivery of bioreductive drug targeting system as oxygen suppresses …Author: Jagruti Patel, Bhatt Jigar, Harshit Shah, Dhavel Patel
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)31491-5/fulltext
Active-controlled study of patients receiving infliximab for the treatment of rheumatoid arthritis of early onset study group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.Author: Gerd R Burmester, Janet E Pope
https://freepaper.me/downloads/abstract/10.1016/j.biopha.2018.07.027
Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic joint inflammation which ultimately leads to severe disability and premature mortality.
https://onlinelibrary.wiley.com/doi/full/10.1002/wnan.1630
Current treatments include on one hand non‐steroidal anti‐inflammatory drugs and gluc... Nanomedicines for the delivery of glucocorticoids and nucleic acids as potential alternatives in the treatment of rheumatoid arthritis - Yu - - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
https://www.sciencedirect.com/science/article/pii/S0753332218306905
4. Novel drug delivery systems in RA management. Conventional drug delivery systems show advantages along with several disadvantages like low solubility and permeability, poor bioavailability, degradation by GI enzymes, first pass metabolism, food interactions, high dose requirement and associated drug toxicity [59].Author: Sourav Thakur, Bushra Riyaz, Akshay Patil, Amanjot Kaur, Bhupinder Kapoor, Vijay Mishra
https://www.sciencedirect.com/science/article/pii/S0049017208001509
The selective inhibitor, celecoxib, used for the treatment of arthritis, was recently reported to have cardiovascular effects and, with the recall of valdecoxib and rofecoxib (103, 104), there may be a significant need for research into other modes of drug delivery. Drugs can be delivered to the upper and deeper layers of skin through topical administration, which bypasses gastric degradation and minimizes systemic side effects …Author: Anne S. Vanniasinghe, Veronika Bender, Nicholas Manolios
https://www.msn.com/en-us/health/medical/treatments-for-covid-19-drugs-being-tested-against-the-coronavirus/ar-BB12oo4L
Chloroquine and hydroxychloroquine Chloroquine and hydroxychloroquine have been approved by the U.S. Food and Drug Administration for the treatment of malaria, lupus and rheumatoid arthritis…
Searching for Novel Drug Delivery Technologies For The Treatment Of Rheumatoid Arthritis?
You can just click the links above. The data is collected for you.
